Moderna and Merck's personalised mRNA cancer vaccine has shown positive Phase 3 results when combined with Keytruda in ...

A study of high-risk melanoma patients, the companies said the experimental treatment using two drugs in combination ...

A personalised mRNA cancer vaccine from Moderna and Merck has met key goals in a Phase 3 melanoma trial. The treatment is ...

President Trump has nominated White House aide Heidi Overton to lead the FDA, amidst challenges like low morale and staff ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big ...

A personalized mRNA vaccine from Moderna and Merck, combined with Keytruda, met its main goal in a late-stage clinical trial for melanoma. The treatment significantly helped prevent high-risk skin ...

RBC Capital Markets analyst Trung Huynh believes most of the biopharma stock swings are due to the AI rotation, but noted that the "extra bounce" on Wednesday is likely the result of excitement around ...

An experimental mRNA-based vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients, Moderna and its partner Merck said Wednesday, paving the way ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of ...

It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna ...